Add like
Add dislike
Add to saved papers

Clinical Relevance of Axial Radiographic Damage in Axial Spondyloarthritis - Evaluation of Functional Consequences by an Objective Electronic Device.

OBJECTIVE: Axial spondyloarthritis (axSpA) is associated with decreased function and mobility of patients due to inflammation and radiographic damage. The Epionics SPINE device (ES), an electronic device that objectively measures spinal mobility, including range of motion (RoM) and speed (RoK) of movement, has been clinically validated in axSpA. We investigated the performance of the ES relative to radiographic damage in the axial skeleton of patients with axSpA.

METHODS: A total of 103 patients with axSpA (31 non- [nr-] and 72 radiographic [r]- axSpA) were consecutively examined. Conventional radiographs of the spine (including presence, number and location of syndesmophytes) and the sacroiliac joints (SIJs, rated by mNY criteria) were analyzed with the ES and assessments of function and mobility using analyses of covariance and Spearman correlation.

RESULTS: The number of syndesmophytes correlated positively with BASMI scores ( r =0.38; P =0.016) and negatively with chest expansion ( r =-0.39; P =0.015) and ES measurements (-0.53 ≤ r ≤ -0.34, P <0.03) except for RoM and RoK regarding rotation and RoK for extension of the lumbar and thoracic spine. In the radiographic evaluation of SIJs, the extent of damage correlated negatively with ES scores and metric measurements (-0.49 ≤ r ≤ -0.33; P <0.001). Patients with r-axSpA showed significantly worse ES scores for RoM, RoK and chest expansion than those with nr-axSpA.

CONCLUSION: The ES scores, in accordance with mobility measurements, correlated well with the presence and extent of radiographic damage in the spine and SIJs. As expected, patients with r-axSpA had more severe impairments than those with nr-axSpA.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app